GlassScriptPhysician profile
Alyse C Russo
NPI 1346516408
$8,457.13
in general payments reported to CMS, 2019-2025
25 companies · $1,814 in 2025
The $1,814 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $457 · 2022: $1,294 · 2023: $3,522 · 2024: $1,370 · 2025: $1,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,338 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $337 · Education: $281 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,337.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $337.05 |
| Education | $281.26 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,563.43 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $1,016.73 | 2021-2025 | Winlevi, Ilumya, Blu-U |
| Mayne Pharma Commercial LLC | $899.56 | 2022-2025 | |
| Medimetriks Pharmaceuticals, INC. | $500.00 | 2022-2023 | Neo-Synalar |
| E.R. Squibb & Sons, L.L.C. | $451.16 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $432.21 | 2023-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $360.51 | 2021-2025 | |
| Leo Pharma INC. | $316.11 | 2021-2025 | Adbry, Anzupgo |
| Pfizer INC. | $315.37 | 2021-2025 | |
| Amgen INC. | $300.45 | 2021-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $233.30 | 2022-2025 | |
| Lilly USA, LLC | $194.60 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $177.67 | 2025 | Tremfya, Stelara, Simponi Aria |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $149.31 | 2021-2025 | Cabtreo, Jublia, Arazlo |
| Allergan, INC. | $126.10 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $111.20 | 2021-2025 | Nemluvio |
| Dermavant Sciences, INC. | $65.27 | 2023-2024 | Vtama |
| Lnhc, INC | $43.69 | 2025 | Zelsuvmi |
| Almirall LLC | $43.15 | 2025 | Seysara, Klisyri |
| Journey Medical Corporation | $43.05 | 2022 | |
| Botanix Sb INC | $37.74 | 2025 | Sofdra |
| Epi Health, LLC | $28.92 | 2021-2022 | |
| Celgene Corporation | $17.99 | 2024 | Sotyktu |
| Strata Skin Sciences, INC. | $14.81 | 2025 | Xtrac |
| Incyte Corporation | $14.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyse Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.